Skip to main content
Log in

Advancements in Osteoporosis Research

Advancements in Osteoporosis Research aims to provide a comprehensive platform for disseminating cutting-edge research and innovations in the field of osteoporosis, with a focus on advancing understanding and improving clinical management strategies. In alignment with Aging Clinical and Experimental Research's commitment to enhancing knowledge in aging-related disciplines, this collection invites contributions that explore various aspects of osteoporosis research. Manuscripts addressing the following themes are particularly encouraged:

·Novel Insights into Osteoporosis Pathophysiology: Original research elucidating the underlying mechanisms contributing to the development and progression of osteoporosis, including genetic, molecular, and cellular pathways.

·Innovations in Diagnostic Techniques: Studies evaluating emerging diagnostic tools and technologies for the accurate and early detection of osteoporosis, as well as advancements in imaging modalities and biomarker discovery.

·Therapeutic Developments and Treatment Strategies: Investigations into novel pharmacological agents, therapeutic interventions, and preventive measures aimed at reducing fracture risk, improving bone health, and enhancing quality of life in individuals with osteoporosis.

·Translational and Clinical Research: Translational studies bridging basic science discoveries with clinical applications, as well as clinical trials evaluating the efficacy and safety of new treatments and interventions for osteoporosis management.

·Multidisciplinary Approaches to Osteoporosis Care: Research highlighting the role of interdisciplinary collaborations, including geriatric medicine, orthopedics, endocrinology, and rehabilitation, in delivering comprehensive and personalized care to patients with osteoporosis.

By fostering collaboration and knowledge exchange among researchers, clinicians, and healthcare professionals, Advancements in Osteoporosis Research seeks to accelerate progress in the prevention, diagnosis, and treatment of osteoporosis, ultimately improving outcomes and quality of life for older adults affected by this prevalent age-related condition.

Participating journal

Submit your manuscript to this collection through the participating journal.

Editors

  • Stefano Gonnelli

    Stefano Gonnelli

    Prof. Gonnelli is a Full Professor of Internal Medicine in the Department of Medical, Surgical & Neurosciences of the University of Siena, Italy. Graduated in Medicine and Surgery from the University of Siena and specialized in Endocrinology, Cardiology and Preventive Medicine, he directed their postgraduate specialization schools in Emergency-Urgency Medicine and in Internal Medicine. He is the President of the Territorial Ethics Committee of the Southeast Tuscany Area. He has been involved in conducting several clinical trials under ICH-GCP in metabolic, osteoporosis, cardiovascular, and diabetes diseases.
  • Mario Bo

    Mario Bo

    A specialist in Geriatrics and Cardiology with a PhD in "Gerontology Research and Geriatric Therapy," Dr. Bo is the author of >200 scientific papers in international journals and Associate Professor, Head of Geriatrics at the University of Turin & Director of the Postgraduate School of Geriatrics. His research focuses on geriatrics (delirium, dementia, sarcopenia, osteoporosis, polypharmacy) and cardiology (atrial fibrillation, syncope, hypertension, aortic stenosis) and internal medicine. He is also a member of the Italian Society of Gerontology and Geriatrics & Italian Society of Geriatric Cardiology.
  • Osvaldo Daniel Messina

    Osvaldo Daniel Messina

    Dr Osvaldo Daniel Messina, physician, rheumatologist and osteologist, is Director of Rheumatology, Cosme Argerich Hospital, Buenos Aires, Argentina. Graduated in medicine at the University of Buenos Aires, Argentina (1977), he is director of the rheumatology training program at their School of Medicine and serves on the Committee of Scientific Advisors of the IOF. Dr Messina is a member of the certification committee in metabolic bone diseases of the Argentine Society of Osteoporosis, the National Academy of Medicine, the Argentine Society of Rheumatology, the American College of Rheumatology and the American Society for Bone and Mineral Rese

Articles

Showing 1 of 1 article

Navigation